EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock enjoyed a major increase of 14.0% on 7/11/24. The shares closed at $9.91. Moreover, trading volume in this advance was unusually high at 163% of normal. The stock has been strong relative to the market over the last nine months and has risen 23.7% during the last week.
Current PriceTarget Research Rating
EYPT is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
EyePoint Pharmaceuticals has a current Value Trend Rating of C (Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. EyePoint Pharmaceuticals has a neutral Appreciation Score of 47 and a slightly positive Power Rating of 62, leading to the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment